Triple negative breast cancer: Clinical characteristics in the different histological subtypes

被引:41
|
作者
Dreyer, Geertje [1 ]
Vandorpe, Thijs [2 ]
Smeets, Ann [2 ]
Forceville, Kathleen [1 ,2 ]
Brouwers, Barbara [1 ,2 ]
Neven, Patrick [2 ,3 ]
Janssens, Hilde [2 ,4 ]
Deraedt, Karen [2 ,5 ]
Moerman, Philippe [2 ,5 ]
Van Calster, Ben [6 ,7 ]
Christiaens, Marie-Rose [2 ]
Paridaens, Robert [1 ,2 ]
Wildiers, Hans [1 ,2 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Gen Med Oncol, Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Multidisciplinary Breast Ctr, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Gynecol Oncol, Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Radiotherapy, Louvain, Belgium
[5] Katholieke Univ Leuven Hosp, Dept Pathol, Louvain, Belgium
[6] Katholieke Univ Leuven Hosp, Dept Elect Engn ESAT SCD, Louvain, Belgium
[7] Katholieke Univ Leuven Hosp, Leuvens Kankerinst, Louvain, Belgium
来源
BREAST | 2013年 / 22卷 / 05期
关键词
Breast cancer; Triple negative; Histology; Outcome; Lymph node involvement; Apocrine breast cancer; EXPRESSION; CARCINOMA; FEATURES; RECEPTOR; RELAPSE;
D O I
10.1016/j.breast.2013.01.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the clinical behavior of triple negative breast cancer (TNC), including age distribution, occurrence of LN (lymph node) invasion and prognosis in different histological subtypes. Methods: For this cohort study we used data on 476 patients with newly diagnosed TNC at the University Hospitals Leuven (Belgium) between 1999 and 2009. Of these, 395 received upfront surgery, 68 neo-adjuvant chemotherapy and 21 had metastases at diagnosis. Results: Apocrine and invasive lobular TNC occur more often in older patients compared to IDC-NOS. Of the primarily operated patients with TNC, 35.1% has pathological LN involvement. There were no significant differences in nodal invasion between different histological subtypes, but most subtypes contained few patients. In contrast to previous reports, 6/14 of apocrine TNC had LN involvement. Disease free survival (DFS) was different in different histological subtypes, but group sizes were insufficient to be able to draw firm conclusions. Within the histologically 'homogeneous' IDC-NOS group with primary surgery and outcome data (n = 300), DFS with 3.5 year median follow-up decreased with increasing age, but chemotherapy and radiotherapy were much less frequently given with increasing age. In multivariable analysis, lower age, presence of LN involvement, lack of administration of chemotherapy and radiotherapy were significant predictors of relapse. Conclusion: TNC is not a uniform disease. Different histological subtypes have different age distribution and behavior. The prognosis of the most common histological subgroup, IDC-NOS, is better in older patients, but this is counterbalanced by significantly decreased use of chemotherapy and radiotherapy. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:761 / 766
页数:6
相关论文
共 50 条
  • [41] Genomic Characteristics of Triple-Negative Breast Cancer Nominate Molecular Subtypes That Predict Chemotherapy Response
    Kim, Jihyun
    Yu, Doyeong
    Kwon, Youngmee
    Lee, Keun Seok
    Sim, Sung Hoon
    Kong, Sun-Young
    Lee, Eun Sook
    Park, In Hae
    Park, Charny
    MOLECULAR CANCER RESEARCH, 2020, 18 (02) : 253 - 263
  • [42] Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Nakano, Masahiro
    Otsuka, Hiroko
    Fujisue, Mamiko
    Arima, Nobuyuki
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [43] Triple negative breast cancer: An analysis of the subtypes and the effects of menopausal status on invasive breast cancer
    Arima, Nobuyuki
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Nakano, Masahiro
    Fujisue, Mamiko
    Otsuka, Hiroko
    CANCER RESEARCH, 2022, 82 (04)
  • [44] Correlation between histology and molecular subtypes in triple negative breast cancer
    Domingos, Tabata Alves
    Peixoto, Roberto Bonfim Pimenta
    Patel, Ashka
    Taneja, Krishan
    Chen, Wendy Y.
    Mittendorf, Elizabeth A.
    Zimbalist, Alexa
    Feliciano, Elizabeth M. Cespedes
    Dillon, Deborah A.
    CANCER RESEARCH, 2023, 83 (05)
  • [45] Prognostic tumor microenvironment subtypes in triple-negative breast cancer
    Eng, Jennifer R.
    Bucher, Elmar
    Hu, Zhi
    Sanders, Melinda
    Chakravarthy, Bapsi
    Gibbs, Summer
    Chin, Koei
    Pietenpol, Jennifer
    Gray, Joe W.
    CANCER RESEARCH, 2022, 82 (12)
  • [46] Novel prognostic stromal subtypes in triple-negative breast cancer
    Thompson, Crista
    Saleh, Sadiq M.
    Bertos, Nicholas
    Gigoux, Mathieu
    Gruosso, Tina
    Souleimanova, Margarita
    Zhao, Hong
    Hallett, Michael T.
    Park, Morag
    CANCER RESEARCH, 2016, 76
  • [47] Identification of new therapeutic leads for triple negative breast cancer subtypes
    Robles, A. J.
    Du, L.
    Cai, S.
    Cichewicz, R. H.
    Mooberry, S. L.
    PLANTA MEDICA, 2015, 81 (11) : 890 - 890
  • [48] Molecular stratification within triple-negative breast cancer subtypes
    Wang, Dong-Yu
    Jiang, Zhe
    Ben-David, Yaacov
    Woodgett, James R.
    Zacksenhaus, Eldad
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [49] Molecular subtypes and precision treatment of triple-negative breast cancer
    Zhao, Shen
    Zuo, Wen-Jia
    Shao, Zhi-Ming
    Jiang, Yi-Zhou
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (07)
  • [50] Clinicopathological Features of Triple-Negative Breast Cancer Epigenetic Subtypes
    Maggie L. DiNome
    Javier I. J. Orozco
    Chikako Matsuba
    Ayla O. Manughian-Peter
    Miquel Ensenyat-Mendez
    Shu-Ching Chang
    John R. Jalas
    Matthew P. Salomon
    Diego M. Marzese
    Annals of Surgical Oncology, 2019, 26 : 3344 - 3353